ABSTRACT: Pharmacologic profiling of serotonin (5HT) receptors of bovine lateral saphenous vein has shown that cattle grazing endophyte-infected (Neotyphodium coenophialum) tall fescue (Lolium arundinaceum) have altered responses to ergovaline, 5HT, 5HT 2A , and 5HT 7 agonists. To determine if 5HT receptor activity of tall fescue alkaloids is affected by grazing endophyte-free (EF), wild-type [Kentucky-31 (KY31)], novel endophyte AR542-infected (MAXQ), or novel endophyte AR584-infected (AR584) tall fescue, contractile responses of lateral saphenous veins biopsied from cattle grazing these different fescue-endophyte combinations were evaluated in presence or absence of antagonists for 5HT 2A (ketanserin) or 5HT 7 (SB-269970) receptors. Biopsies were conducted over 2 yr on 35 mixed-breed steers (361.5 ± 6.3 kg) grazing EF (n = 12), KY31 (n = 12), MAXQ (n = 6), or AR584 (n = 5) pasture treatments (3 ha) between 84 and 98 d (Yr 1) or 108 to 124 d (Yr 2). Segments (2 to 3 cm) of vein were surgically biopsied, sliced into 2-to 3-mm cross-sections, and suspended in a myograph chamber containing 5 mL of oxygenated Krebs-Henseleit buffer (95% O 2 /5% CO 2 ; pH = 7.4; 37°C). Veins were exposed to increasing concentrations of 5HT, ergovaline, and ergovaline + 1 × 10 -5 M ketanserin or + 1 × 10 -6 M SB-269970 in Yr 1. In Yr 2, ergotamine and ergocornine were evaluated in presence or absence of 1 × 10 -5 M ketanserin. Contractile response data were normalized to a reference addition of 1 × 10 -4 M norepinephrine. In Yr 1, contractile response to 5HT and ergovaline were least (P < 0.05) in KY31 pastures and the presence of ketanserin greatly reduced (P < 0.05) the response to ergovaline in all pastures. However, presence of SB-269970 did not (P = 0.91) alter contractile response to ergovaline. In Yr 2, there was no difference in contractile response to ergotamine (P = 0.13) or ergocornine (P = 0.99) across pasture treatments, but ketanserin reduced (P < 0.05) the contractile response to both alkaloids. The 5HT 2A receptor is involved in alkaloid-induced vascular contraction and alkaloid binding may be affected by exposure to different endophyte-fescue combinations.
INTRODUCTION
Ergot alkaloids produced by the fungal endophyte Neotyphodium coenophialum in tall fescue (Lolium arundinaceum) have been shown to bind a variety of monaminergic receptors, including serotonin (5HT; Dyer and Gant, 1973; Dyer 1993; Schöning et al., 2001 ), α-adrenergic (Oliver et al., 1998) , and dopaminergic (Larson et al., 1999) receptors. This receptor promiscuity, combined with anatomic variability of receptor populations and receptor sites within the body, has made understanding how ergot alkaloids cause vasoconstriction challenging. This is further complicated as affinities and activities for these receptor sites vary as a result of slight differences in alkaloid structural configurations (Berde, 1980) . Serotonin receptors have been shown to be involved with ergoline alkaloid-(lysergic acid diethyl amide; Dyer and Gant, 1973) and ergopeptide alkaloid-induced (ergovaline; Dyer, 1993) vasoconstriction. More specifically, the constrictive effects of ergovaline were demonstrated to be mediated via 5HT 2A and 5HT 1B/1D receptors in rat tail and guinea pig iliac arterial preparations (Schöning et al., 2001) . A complete understanding of how exposure to tall fescue ergot alkaloids results in peripheral vasoconstriction and consequential fescue toxicosis requires knowledge of the receptor or receptors that the alkaloids bind. Klotz et al. (2012) has shown that lateral saphenous vein 5HT 2A and 5HT 7 receptors are differently affected by grazing high endophyte-infected tall fescue pastures. Given that the different subtypes of 5HT receptors are found in differing active populations in various tissues, it is necessary to determine if ergot alkaloids interact with these receptors in bovine peripheral vasculature. Therefore, the objective of this experiment was to determine if grazing steers on different tall fescue-endophyte combinations affects the contractile response of bovine lateral saphenous veins to ergovaline, ergotamine, and ergocornine in the presence of 5HT 2A or 5HT 7 receptor antagonists.
MATERIALS AND METHODS
All experimental procedures involving live steers were approved by the University of Kentucky Institutional Animal Care and Use Committee (protocol number 2007-0254).
Animals and Pastures
Experiment 1. Lateral saphenous vein biopsies were conducted on 18 mixed-breed (predominantly Angus) steers (350 ± 9 kg) after the completion of a separate grazing trial that was described in detail by Johnson et al. (2012) . All pasture infection levels and pasture alkaloid concentrations for both Exp. 1 and 2 were reported by Johnson et al. (2012) . Experiment 1 took place in 2008 and steers grazed for 84 to 98 d on 3-ha pastures of Kentucky-31 (KY31) tall fescue infected with the wildtype endophyte (n = 6), an endophyte-free (EF) tall fescue (KYFA9301; n = 6), or a 'Jesup' tall fescue infected with the novel endophyte AR542 (MAXQ; n = 6).
Experiment 2. After the second year of Johnson et al. (2012) , 17 mixed-breed steers (373 ± 7 kg) were biopsied after grazing 108 to 124 d on the same 3-ha EF (n = 6) and KY31 (n = 6) pastures as in Exp. 1, but instead of MAXQ, steers grazed a KYFA9301 pasture infected with a different novel endophyte (AR584; n = 5). Blood samples were collected from a jugular vein as the steer was undergoing the saphenous vein biopsy. Serum was collected after centrifugation at 3,000 × g for 10 min at 20°C. Using the procedures of Bernard et al. (1993) , serum prolactin analysis was conducted by the laboratory of F. N. Schrick (University of Tennessee, Knoxville). The intra-assay CV was 6.8%.
Lateral Saphenous Vein Biopsies
For both Exp. 1 and 2, 1 steer from each pasture treatment (n = 3) was brought directly from the pasture to holding pens near the biopsy facility and biopsied that morning. The order in which a steer from a given pasture treatment was chosen for biopsy was random. The biopsy procedure of the cranial branch of the lateral saphenous vein was published in detail by Klotz et al. (2008) . Isolated and excised venous tissue samples (approximately 2 cm) were placed in a modified KrebsHenseleit oxygenated buffer solution (95% O 2 /5% CO 2 ; pH = 7.4; millimolar composition = D-glucose, 11.1; MgSO 4 , 1.2; KH 2 PO 4 , 1.2; KCl, 4.7; NaCl, 118.1; CaCl 2 , 3.4; and NaHCO 3 , 24.9; Sigma Chemical Co., St. Louis, MO) for transport and kept on ice until processed. Immediately after biopsy, steers received intramuscular injections of 6,600 U/kg of BW of penicillin (Procaine G; Norbrook Inc., Kansas City, MO) and 1.1 mg/kg of BW of flunixin meglumine (Flunixiject; IVX Animal Health Inc., St. Joseph, MO) and penned in a drylot for observation and the administration of flunixin meglumine for 2 d postbiopsy.
Myograph Experiments
Myograph experiments were conducted as described by Klotz et al. (2006) . The biopsied vein section was cleaned of external adipose and connective tissues and sliced into 2-to 3-mm cross-sections. These crosssections were suspended on luminal supports in duplicate (per myograph treatment) in individual chambers of a multimyograph (DMT 610M; Danish Myo Technology, Atlanta, GA) containing 5 mL of continuously gassed (95% O 2 /5% CO 2 ) modified Krebs-Henseleit buffer (37°C). The incubation buffer was the transport buffer plus 3 × 10 -5 M desipramine and 1 × 10 -6 M propranolol (Sigma Chemical Co.). Depending on the treatment assignment, the Krebs buffer also contained 1 × 10 -5 M ketanserin tartrate (S006; Sigma Chemical Co.) or 1 × 10 -6 M SB-269970 HCl (S7389; Sigma Chemical Co.). Venous cross-sections were allowed to equilibrate in this environment under a set resting tension of 1 g for 90 min, with buffer replacement occurring at 15-min intervals. After equilibration, veins were exposed to a reference addition of 1 × 10 -4 M norepinephrine (Sigma Chemical Co.) to ensure tissue responsiveness. Viable tissues were again washed with incubation buffer that was replaced at 15-min intervals. Once relaxation to the 1-g resting tension was achieved, the cumulative contractile response experiments were initiated.
Treatment additions occurred at 15-min intervals that consisted of a 9-min incubation period followed by a washout period during which duplicate aliquots of buffer minus the treatment were incubated with the vein segment for two 2.5-min periods followed by a final buffer replacement and 1-min incubation before the next addition. After the final high concentration addition of a treatment, the experiment was concluded with a final addition of 1 × 10 -4 M norepinephrine to verify that the vein cross-sections were still viable for the full duration of the experiment. Additions for Exp. 1 consisted of increasing concentrations of serotonin HCl (in water; H9523; Sigma Chemical Co.), ergovaline (in methanol; provided by Forrest Smith, Auburn University, Auburn, AL), ergovaline + 1 × 10 -5 M ketanserin (a selective 5HT 2A antagonist), and ergovaline + 1 × 10 -6 M SB-269970 (a selective 5HT 7 antagonist). In Exp. 2, the experimental additions to the vein cross-sections in the myograph were increasing concentrations of the ergot alkaloids ergotamine D-tartrate (in methanol; 45510; Fluka, as distributed by Sigma Chemical Co.) and ergocornine (in dimethyl sulfoxide; E131; Sigma Chemical Co.) in the presence and absence of 1 × 10 -5 M ketanserin. For both experiments, treatments were added in volumes that did not exceed 0.5% of the total volume of the myograph chamber. Stock concentrations of treatments ranged from 2.01 × 10 -9 to 2.01 × 10 -2 M (except ergotamine, which had a high concentration of 2.01 × 10 -3 M) and were added to myograph chambers in 0.025-mL aliquots to yield final working concentrations that ranged from 1 × 10 -11 to 1 × 10 -4 M.
Data and Statistical Analyses
Data were digitized and recorded using a Powerlab/8sp and Chart software (ADInstruments, Colorado Springs, CO). The contractile responses were recorded as the greatest tension (g) detected within the 9-min incubation period. All tensions were corrected by the baseline established during the interval just before the addition of the norepinephrine (1 × 10 -4 M) reference treatment, thereby generating cumulative contractile responses. To compensate for variation of tissue responsiveness due to differences in tissue size or individual animal variation, values were normalized as a percentage of the maximal contraction produced by norepinephrine. All contractile response data presented for both experiments were plotted using GraphPad Prism software (San Diego, CA). This used a nonlinear regression (sigmoidal concentrationresponse curve) to fit a line to contractile response data using the 4 parameter equation:
( ) of a particular agonist required to produce 50% contractile response of a vessel (EC 50 ). Prolactin concentration, BW, and vascular dimension data for both Exp. 1 and 2 and 5HT EC 50 data for Exp.1 were analyzed as completely randomized designs using the mixed models procedure (SAS Inst. Inc., Cary, NC) for the effect of pasture. Contractile response data for 5HT and EC 50 data (except for 5HT) were analyzed with a split plot treatment design with pasture as the whole plot and 5HT concentration as the subplot. Steer and saphenous vein were the whole and subplot experimental units, respectively, with steer within pasture as the whole plot error term. Because contractile response data to ergovaline, ergotamine, and ergocornine were evaluated alone or in the presence of different antagonists, a splitsplit plot treatment arrangement was used. Pasture, antagonist, and alkaloid concentration were the whole plot, subplot, and sub-subplot treatments, respectively. Steer, lateral saphenous vein, and individual crosssections of the saphenous vein were experimental units for the whole plot, subplot, and sub-subplot, respectively. Error terms were steer within pasture and antagonist × steer within pasture for the whole plot and subplot, respectively. For all datasets, pairwise comparisons of least square means (±SEM) were conducted if the probability of a greater F-statistic was significant for the effect or interaction being tested. Pairwise comparisons were conducted using the LSD feature of SAS and the macro pdmix700 (Saxton, 1998) to group differences. Probabilities discussed as significant are P < 0.05, unless specifically reported otherwise.
RESULTS

Experiment 1
Animals. All 18 steers were biopsied within a 2-wk interval. There were no (P = 0.36) differences in BW at the time of biopsy across pasture type (Table 1) . Prolactin concentrations were not measured at the time of biopsy in Exp. 1 but were measured when these steers were part of a grazing study using the same pastures. The grazing study (Johnson et al., 2012) ended 1 wk before initiation of the saphenous vein biopsies and reported mean prolactin concentrations of 102.8 ± 12.6, 64.9 ± 7.7, and 183.22 ± 34.9 ng/mL for EF, KY31, and MAXQ steers that were to be biopsied, respectively. The i.d. for biopsied lateral saphenous veins differed (P < 0.01) across all 3 pasture types in Exp. 1, with veins from KY31 having the smallest and MAXQ having the largest i.d.; however, o.d. did not (P = 0.39) differ among treatments.
Serotonin Response. The steers on MAXQ pasture had the greatest response (P < 0.05) at both 1 × 10 -5 and 1 × 10 -4 M 5HT whereas the steers that grazed KY31 had the least (P < 0.05) at 1 × 10 -4 M (Fig. 1) . There was no difference (P = 0.17) in the EC 50 of 5HT across pasture type (Table 2) .
Ergovaline Response. There was a pasture × ergovaline response interaction, with a greater (P < 0.05) response to ergovaline in MAXQ than EF, both of which were greater than KY31 (Fig. 2) . Within each pasture treatment there was an interaction of antagonist × ergovaline response (P < 0.01). The presence of the 10 μM ketanserin (5HT 2A antagonist) in the KrebsHenseleit buffer solution reduced the contractile response to ergovaline across all pastures whereas the presence of 1 μM SB-269970 (5HT 7 antagonist) did not affect the ergovaline response. The maximal contractile response (1 × 10 -4 M ergovaline) induced by ergovaline in the presence of ketanserin decreased by 73% for EF ( Fig. 2A) , 69% for KY31 (Fig. 2B) , and 58% in the MAXQ (Fig. 2C) veins compared with the response to ergovaline with no antagonist. There was no (P = 0.98) interaction of pasture treatment × antagonist treatment × ergovaline response; therefore, pasture grazed did not change the effect that an antagonist had on the response to ergovaline.
There was a pasture × antagonist interaction (P < 0.01) for the EC 50 of ergovaline (Table 2) . This is a result of the divergent effect that ketanserin had on the EC 50 of ergovaline in the KY31 compared with the EF and MAXQ grazed steers. When evaluating the effects of the antagonists in relation to how pasture affected the EC 50 , the exposure of KY31 veins to ketanserin decreased (P < 0.05) the EC 50 (increased the potency) of ergovaline compared with SB-269970 or no antagonist whereas the opposite effect was observed in EF veins where ketanserin raised (P < 0.05) the EC 50 (less potent) to ergovaline. The EC 50 for MAXQ veins followed the same (P = 0.97) pattern as EF veins. The EC 50 , however, only tended to be lower in the presence of SB-269970 (P = 0.08) compared with the response to ergovaline in the presence of ketanserin.
Experiment 2
Animals. All 17 steers were biopsied within a 16-d interval, and at the time of biopsy, BW did not (P = 0.41) differ across pasture type (Table 1) . Serum prolactin concentrations at the time of biopsy were less (P < 0.05) in KY31 steers than steers grazing EF and the nontoxic endophyte-infected AR584 (Table 1) . The comparison of i.d. vascular dimension was similar to Exp. 1, where KY31 had the smallest (P < 0.05) and AR584 had the largest (P < 0.05) i.d. Unlike Exp. 1, however, steers grazing KY31 had the smallest (P < 0.05) and AR584 the largest (P < 0.05) vessel o.d.
Ergotamine Response. Even though there was a pasture × ergotamine response interaction (P = 0.005), the maximal response to ergotamine was not (P > 0.17) different in KY31 (Fig. 3B) , EF (Fig. 3A) , and AR584 veins (Fig. 3C ). This interaction was likely due to the different effect the inclusion of ketanserin had on veins from KY31 grazed steers. The presence of ketanserin in the incubation buffer reduced (P < 0.01) the contractile response to ergotamine, regardless of the pasture treatment, which corresponded to the observed decrease in contractile response to ergovaline in the presence of ketanserin in Exp. 1. There was no (P = 0.17) interaction between pasture, antagonist, and ergotamine response, indicating that pasture did not affect the antagonist effect on the contractile response to ergotamine. However, there is evidence that the KY31 veins (Fig. 3B) were less affected by the presence of ketanserin, as evidenced by a smaller decrease in the maximal response of KY31 veins (27%) compared with the EF and the AR584 veins (56 and 57%, respectively) as well as the lowering effect (P = 0.06) ketanserin had on the EC 50 of ergotamine in KY31 veins compared with ergotamine alone (Table 2) . Ketanserin did not (P ≥ 0.17) affect the EC 50 of ergotamine in veins biopsied from EF and AR584 steers. Ergocornine Response. Although there was no (P = 0.99) pasture × ergocornine response interaction, there was an interaction (P < 0.01) of ketanserin on the contractile response induced by ergocornine. The percent decrease in maximal response to ergocornine caused by ketanserin was 72, 70, and 69% for EF (Fig. 4A) , KY31 (Fig. 4B) , and AR584 (Fig. 4C) , respectively. Like ergotamine and ergovaline, the presence of ketanserin caused the EC 50 for KY31 veins to decrease (P < 0.05) and become more potent than ergocornine alone (Table 2) ; however, there was no (P ≥ 0.21) difference in the ergocornine EC 50 in the presence or absence of ketanserin for either EF or AR584 veins.
DISCUSSION
Effect of Fescue-Endophyte Combinations on Contractile Response
The contractile response of lateral saphenous veins to ergovaline and 5HT were suppressed in steers grazing KY31, which agrees with a previous report by that demonstrated a decrease in response by these 2 compounds in steers that grazed high-vs. lowendophyte-infected tall fescue pastures. Although serum samples were not collected for prolactin analysis the day of biopsy in Exp. 1, prolactin concentrations reported by Johnson et al. (2012) in the same steers during the grazing experiment were less on KY31 than on EF or MAXQ pastures. Interestingly, the MAXQ vessels had greater responses than the EF veins to both 5HT and ergovaline. Ergocornine + ketanserin, M -4.65 ± 0.09 b -5.24 ± 0.10 a -4.74 ± 0.11 b -a-c Within a row, least squares means lacking a common superscripted letter differ, P < 0.05. 1 Data for effective concentrations at which 50% of the contractile response is realized (EC 50 ) were calculated from additions of a treatment increasing in concentration whereas the antagonists ketanserin (5HT 2A antagonist; 1 × 10 -6 M) and SB-269970 (5HT 7 antagonist; 1 × 10 -7 M) concentrations were held constant in the myograph baths. Serotonin additions were not evaluated with either antagonist (-); therefore, only the effect of pasture was tested.
2 Data are means of 6 steers per pasture except the AR584-infected tall fescue pasture, which was n = 5 steers. Steers that grazed AR584 pastures were not biopsied (-) in Exp. 1 and steers that grazed MAXQ were not biopsied in Exp 2.
3 Probablility of a greater F statistic for pasture (PAST), antagonist (A), and the PAST × A interaction.
The ergopeptide alkaloids ergotamine and ergocornine were chosen for evaluation because each is structurally different than ergovaline at only single locations on the tricyclic peptide moiety (Klotz et al., 2010) . This was the first time ergotamine and ergocornine contractile responses were evaluated relative to a pasture treatment. Unlike ergovaline in Exp. 1, there was no pasture effect for either alkaloid without ketanserin in Exp. 2. This was initially thought to be a result of a Kentucky bluegrass (Poa pratensis L.) encroachment that occurred in 2009 (Johnson et al., 2012) and, due to the amount of encroachment, was the primary rationale for switching from MAXQ to AR584 novel endophyte in Exp. 2. The KY31-grazed steers, however, were observed to selectively graze tall fescue (Johnson et al., 2012) and had decreased prolactin concentrations, and the KY31 pasture alkaloid concentrations were greater in Exp. 2 than 1 (Johnson et al., 2012) . This would indicate that there was adequate alkaloid exposure through the KY31 pasture treatment; therefore, the absence of a suppressed response to ergotamine and ergocornine in KY31-grazed steers is likely due to differing modes of action of these alkaloids compared with ergovaline.
Steers grazing KY31 were displaying signs of ergot alkaloid exposure as evidenced by reduced prolactin concentrations and altered vascular dimensions at the time lateral saphenous veins were collected. The suppression of ergovaline and 5HT responses seen in Exp. 1 was hypothesized to be a result of a mitigated population of open receptor binding sites or an affected secondary messaging system associated with these G protein coupled receptors (Oliver, 1997; Bhatnagar et al., 2001) . Although responses to ergotamine and ergocornine did not differ across pastures, their mode of action could still be evaluated through receptor antagonism.
Effect of Receptor Antagonism on Contractile Response
The antagonist, ketanserin, was selected because it targets the 5HT 2A receptor and ketanserin use has been well documented from the late 1970s (Van Nueten et al., 1987) . Using ketanserin, Dyer (1993) antagonized ergovalineinduced contractile responses in the bovine uterine artery and Schöning et al. (2001) antagonized ergotamine-and ergovaline-induced contractile responses in rat tail artery. Klotz et al. (2012) reported that lateral saphenous veins collected from steers grazing high endophyte-infected tall fescue pasture had reduced contractile responses to 5HT, ergovaline, and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride, a 5HT 2A receptor agonist. Results of the current study confirmed that antagonism of 5HT 2A receptor suppressed the contractile response of ergovaline and ergotamine and demonstrated for the first time that this happens in bovine peripheral venous vasculature. Also, this study is the first to demonstrate that the lateral saphenous vein contractile response to ergocornine is antagonized by the 5HT 2A receptor antagonist ketanserin. The antagonism of the 5HT 2A receptor resulted in a dextral shift and reduced maximal response of the contractile response curve for all 3 alkaloids tested in all pasture treatments. There was one unexpected observation made as a result of the 5HT 2A receptor antagonism. Across Exp. 1 and 2, the antagonism of the 5HT 2A receptor caused the EC 50 to decrease (an increase in potency of the test compound) for the KY31 pasture treatment only. This is an indication that there is an increase in the sensitivity to ergovaline, ergotamine, and ergocornine in the lateral saphenous veins isolated from steers that grazed KY31 and that the chronic exposure to ergot alkaloids that occurs through grazing toxic endophyte-infected tall fescue pastures alters vasculature at the receptor level. This could be a result of an increased interaction with α-adrenergic receptors, which have been demonstrated to have an increased reactivity in lateral saphenous veins collected from cattle that had grazed toxic endophyte-infected tall fescue (Oliver et al., 1998) .
Discovery of the 5HT 7 receptor was relatively recent (Bard et al., 1993) as well as subsequent identification of functional antagonists, such as SB-269970 Lovell et al., 2000) . Klotz et al. (2012) demonstrated an increased response to 5-carboxamidotryptamine (5HT 7 receptor agonist) in steers that had grazed high endophyte-infected tall fescue pastures compared with steers that had grazed low endophyte-infected pastures. There was a complete absence of any difference in contractile response to ergovaline as a result of the antagonism of the 5HT 7 receptor in Exp. 1. The role of this receptor is predominantly involved in vasorelaxation (Hoyer et al., 2002) , which was not evaluated in the current study. It was anticipated that an alkaloid interaction with this receptor would manifest as a pasture effect and possibly as an increased contractile response to an ergot alkaloid. Because this did not occur, it is thought that the observations made by Klotz et al. (2012) could be a result of 5-carboxamidotryptamine interacting with 5HT 1 receptors (Borton et al., 1990) The suppression of ergovaline-, ergotamine-, and ergocornine-induced contractile responses by antagonism of the 5HT 2A receptor with ketanserin has demonstrated the relevance of this receptor in the peripheral vasoconstriction observed in fescue toxicosis. Receptor antagonism as a means of mitigating the effects of ergot alkaloids is a tempting solution to the fescue toxicosis syndrome. This has been done with some success but not at a peripheral level. Because the alkaloids evaluated in the current study have been shown to bind receptors in a seemingly irreversible manner (Silberstein, 1997; Schöning et al., 2001; Klotz et al., 2009) , administration of an antagonist (such as ketanserin) would have to be done before ergot alkaloid exposure (Schöning et al., 2001 ). Although it is clear that ergot alkaloids bind numerous receptors types and subtypes, it is, unfortunately, unclear which would be the best receptor to antagonize as a solution for the grazing steer.
In conclusion, antagonism of the 5HT 2A receptor reduced contractile responses to ergovaline, ergotamine, and ergocornine in all fescue-endophyte combinations evaluated. The involvement of this specific receptor in alkaloid-induced contractile response has only been reported previously in arterial models, and this is the first report of this effect in bovine peripheral venous vasculature. Results of this study substantiate that the 5HT 2A receptor is directly involved in mediating tall fescue alkaloid-induced vascular contraction. Steers that grazed the KY31 endophyte-infected tall fescue pastures were more sensitive to decreased concentrations of ergovaline, ergotamine, and ergocornine. Receptor populations and corresponding intracellular signaling pathways may be affected by exposure to ergot alkaloids. Administration of antagonists for receptors, such as 5HT 2A , may be effective in reducing the effects of fescue toxicosis related to vasoconstriction, but prior exposure or alkaloid saturation of the steer must be considered.
LITERATURE CITED
